Back to search

Poland· PL-100042633

Mentho-Paraffinol Hasco

A liquid paraffin product containing paraffinum liquidum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC A06AA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMentho-Paraffinol HascoATCA06AA01REGISTER NO.PL-100042633PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Liquid paraffin is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AA01 (liquid paraffin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Liquid paraffin · ATC A06AA01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Paraffinum liquidum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
A06AA01
ATC class
Liquid paraffin
Defined daily dose
15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990681914

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

256 interactions on record for liquid paraffin.

Graded by severity as the source publishes them — 254 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Liquid paraffin · interactions on record

256 records

  • 254 moderate
  • 2 minor

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/39d4aa1a-a6b5-45ad-8c54-068fb1ffd108
GET /v1/drugs/39d4aa1a-a6b5-45ad-8c54-068fb1ffd108?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór doustny",
  "source": "urpl",
  "strength": "998,75 mg/g",
  "packaging": "05909990681914 ¦ OTC ¦ 1363\n1 op. 125 g",
  "substance": "Paraffinum liquidum 998.75 mg/g",
  "common_name": "Paraffinum liquidum",
  "pl_product_id": "100042633",
  "pozwolenie_nr": "06819",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about liquid paraffin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.